Review: low-dose dopamine does not reduce mortality or need for renal replacement therapy.
نویسندگان
چکیده
منابع مشابه
Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.
BACKGROUND Low-dose dopamine is commonly administered to critically ill patients in the belief that it reduces the risk of renal failure by increasing renal blood flow. However, these effects have not been established in a large randomised controlled trial, and use of dopamine remains controversial. We have done a multicentre, randomised, double-blind, placebo-controlled study of low-dose dopam...
متن کاملHigh-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis.
OBJECTIVE To determine the effect of renal replacement therapy dose on mortality and dialysis dependence in patients with acute kidney injury. DATA SOURCES MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials to October 2009; PubMed "Related Articles;" bibliographies of included trials; and additional information from trial authors. STUDY SELECTION Randomized and quasi-ra...
متن کاملRenal replacement therapy in intensive care unit.
Acute renal failure requiring renal replacement therapy (RRT) is a frequent complication in critically ill patients with high morbidity and mortality. Early prediction of who is going to need RRT is clinically useful in the intensive care unit (ICU). Patients' with diuretic resistant pulmonary edema, hyperkalemia/metabolic acidosis refractory to medical therapy and uremic complications (pericar...
متن کاملDopamine-Synthesizing Neurons: An Overview of Their Development and Application for Cell Therapy
Cell-gene therapy is a dynamic constituent of novel medical biotechnology. Neurodegenerative disordersin which damage to or demise of specific brain cell types plays central role, are clear examples of diseasecandidate for cell replacement therapy. Dopaminergic (DAergic) neurons biosynthesize dopamine, a vitalneurotransmitter in the central nervous system. Due to the involveme...
متن کاملReview: fenoldopam reduces acute kidney injury and death in critical illness.
M e t h o d s Data sources: BioMedCentral, Cochrane Central Register of Controlled Trials, PubMed (to 30 October 2005), conference proceedings, bibliographies of retrieved articles, and experts in the field. Study selection and assessment: Randomized controlled trials (RCTs) in any language that evaluated fenoldopam in critically ill patients (surgical or intensive care unit [ICU]). Studies rel...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- ACP journal club
دوره 143 2 شماره
صفحات -
تاریخ انتشار 2005